The role of the classical pathway for the bactericidal effect of normal sera against gram-negative bacteria.
D000818:Animals; D003166:Complement Activating Enzymes / Q000172:deficiency / Q000378:metabolism; D003167:Complement Activation; D003172:Complement C1 / Q000378:metabolism; D015922:Complement C1q; D003171:Complement Pathway, Classical; D004492:Edetic Acid / Q000494:pharmacology; D004533:Egtazic Acid / Q000494:pharmacology; D004926:Escherichia coli / Q000276:immunology; D004927:Escherichia coli Infections / Q000276:immunology; D006090:Gram-Negative Bacteria / Q000276:immunology*; D006168:Guinea Pigs; D006801:Humans; D007710:Klebsiella Infections / Q000276:immunology; D007711:Klebsiella pneumoniae / Q000276:immunology; D008070:Lipopolysaccharides; D012475:Salmonella / Q000276:immunology
D003172:Complement C1; D008070:Lipopolysaccharides; D004533:Egtazic Acid; D015922:Complement C1q; D004492:Edetic Acid; D003166:Complement Activating Enzymes